Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mild to moderate intermittent claudication: supervised exercise programmes versus cilostazol therapy
2005-002327-13Phase 4Unknown
- Sponsor
- Heart of England NHS Foundation Trust
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cilostazol in intermittent claudication (IC) and arteriosclerosis obliterans (2 arms), sponsored by Heart of England NHS Foundation Trust. Primary endpoint: Improvement in absolute walking distance. Status: unknown.
02
Drugs
cilostazol
03
Conditions
intermittent claudication (IC)arteriosclerosis obliterans
Beyond the preview
Go deeper on 2005-002327-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002327-13.